14 Jul 2017 15:30
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1 | Issuer | Oxford BioMedica PLC |
2 | Reason for notification | Notification relates to DTR 3.1.2R |
3 | Name of PDMR | Martin Diggle |
4 | Connected person | Notification relates to following connected persons: Vulpes Testudo Fund |
5 | Notification in respect of | Notification in respect of holdings of persons in 4 above |
6 | Description of shares | Oxford BioMedica PLC ordinary shares of 1p each |
7 | Name of registered shareholders and number of shares | Vulpes Life Sciences Fund - 549,932,000 shares Vulpes Testudo Fund - 33,333,333 shares
|
8 | Nature of transaction | Acquisition and Disposal |
9 | Number of shares acquired
| Vulpes Testudo Fund - 660,000 shares
|
10 | Percentage of issued class acquired | Vulpes Testudo Fund- 0.02%
|
11 | Shares disposed | Vulpes Testudo Fund - 658,899
|
12 | Percentage of issued class disposed | Vulpes Testudo Fund - 0.02%
|
13/14 | Price per share of transactions, and date | Vulpes Testudo Fund Sold 658,899 shares @ £0.1003, 13 Jan 2017 Bought 660,000 shares @ £0.089, 13 Jan 2017
|
15 | Total holding following notification and total percentage holding following notification | Vulpes Life Sciences Fund - 549,932,000 shares 17.8% Vulpes Testudo Fund - 33,334,434 shares 1.1% |
16 | Date issuer informed | 14 July 2017 |
23 | Any additional information | None |
24 | Contact name and telephone number | T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000 |
Oxford Biomedica (OXB)